Article Text

PDF

020 Comprehensive cardiovascular magnetic resonance assessment of anderson-fabry cardiomyopathy- natural history and assessment of treatment effect
  1. Anna Reid,
  2. Chris Miller,
  3. Ana Jovanovic,
  4. Peter Woolfson,
  5. Nik Abidin,
  6. David Clark,
  7. Wendy Gamlin,
  8. Glyn Coutts,
  9. Matthias Schmitt

Abstract

Background The Anderson Fabry Cardiomyopathy (AFC) is heterogeneous, complex, and its pathophysiology remains incompletely understood. There is uncertainty regarding the optimal timing and impact of enzyme replacement therapy (ERT) in cardiac involvement, with a pressing need for biomarkers able to identify early disease, monitor and guide treatment.

Objectives The aims of this study were two-fold: 1) to perform comprehensive cardiac phenotyping in a large cohort of Anderson-Fabry disease (AFD), and 2) characterise their short-term natural history and assess the impact of ERT using multi-parametric Cardiac Magnetic resonance imaging (MPCMRi), echocardiography and ECG analysis.

Methods 113 prospectively enrolled, genetically-confirmed, AFD patients were compared to 20 age-matched healthy volunteers (HVs). 37 of these patients re-attended for a one-year follow-up scan, and were sub-grouped according to treatment status (newly started on ERT, ERT naïve, and established on ERT).

Results The AFC is characterised by increased LV mass of several different hypertrophic patterns, impaired LV global longitudinal strain and left atrial function, low myocardial native T1, high T2, and increased extracellular volume fraction. Significantly higher T1s were seen in the inferolateral wall, even before the development of increased wall thickness or LV mass, or LGE. A newly proposed marker of disease severity, the ‘T1 ratio’, reflects the relationship between inferolateral and remote myocardial T1, and strongly correlated with LV mass, percentage LGE and ECV fraction, whilst avoiding potential uncertainty caused by pseudo-normalisation of T1s in severe AFD.

ERT initiation reduced LVM. T1 values (excluding the inferolateral wall) fell significantly in untreated patients (974±36 ms v 955±44 ms, p=0.04) associated with a significant increase in voxel based spread (288 v 350, p=0.02), whereas both treatment groups showed no change in T1 values. The T1 ratio showed a trend towards improvement (0.94±0.08 v 0.98±0.1, p=0.05) in the established ERT group. Electrocardiography and echocardiography did not detect disease progression or treatment effects in any group.

Conclusions AFC is a complex pathology with intracellular and extracelluar disease components. MPCMRi elucidates these disease processes and allows early disease detection, and possibly disease and treatment monitoring.

  • Anderson-Fabry disease
  • T1/T2 mapping
  • T1-ratio
  • Extracellular Volume Fraction
  • Left Ventricular Hypertrophy
  • Left Atrial function

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.